NCT02223416View on ClinicalTrials.gov

A Study Aimed at Assessing the Pharmacokinetic Properties of RGB-10 and Forsteo

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Primary Completion Date

January 31, 2015

Conditions
Healthy
Interventions
DRUG

RGB-10

DRUG

Teriparatide

Trial Locations (1)

Unknown

Celerion (UK), Belfast

Sponsors
All Listed Sponsors
lead

Gedeon Richter Plc.

INDUSTRY

NCT02223416 - A Study Aimed at Assessing the Pharmacokinetic Properties of RGB-10 and Forsteo | Biotech Hunter | Biotech Hunter